3 ms·
If 23andMe marketed their service purely for, say, genealogical purposes, there wouldn't be an obvious problem. Instead, they not only report on disease-related
by carbocation 13y ago
If 23andMe marketed their service purely for, say, genealogical purposes, there wouldn't be an obvious problem. Instead, they not only report on disease-related SNPs, but try to interpret those into a coherent diagnostic message.
In my opinion, this is stepping into the FDA's realm of regulation.
- spikels 13y agoCan't disagree with you there. Seems like their original plan of testing for genetic risk factors for a large number of diseases will require lengthy approvals for each and perhaps require conditions such as counseling that are not compatable with a kit. My original comment was more a snark about the free pass the FDA gives to the supplement industry. This is a much less settled area so it is unclear if some fudge like I suggest could work either with the FDA or in the market. Perhaps they will even seek legislative of legal relief like the supplements industry.